EP Patent

EP2736501B1 — Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol

Assigned to Gruenenthal GmbH · Expires 2017-12-20 · 8y expired

What this patent protects

Patent listed against tapentadol-hydrochloride.

Drugs covered by this patent

tapentadol-hydrochloride (TAPENTADOL HYDROCHLORIDE)

Patent Metadata

Patent number: EP2736501B1
Jurisdiction: EP
Classification: —
Expires: 2017-12-20
Drug substance claim: No
Drug product claim: No
Assignee: Gruenenthal GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.